October Journal Club: International Natural Procreative Technology Evaluation and Surveillance of Treatment for Sub-fertility (iNEST): enrollment and methods
1 Stanford, J. B., Parnell, T., Kantor, K., Reeder, M. R., Najmabadi, S., Johnson, K., Musso, I., Hartman, H., Tham, E., Winter, I., Galczynski, K., Carus, A., Sherlock, A., Golden Tevald, J., Barczentewicz, M., Meier, B., Carpentier, P., Poehailos, K., Chasuk, R., Danis, P., Lipscomb, L. (2022). International Natural Procreative Technology Evaluation and Surveillance of Treatment for Subfertility (iNEST): enrollment and methods. Human reproduction open, 2022(3), hoac033. https://doi.org/10.1093/hropen/hoac033
New research sponsored by the IIRRM, and involving multiple IIRRM members, was published earlier this year! This study was the first multi-clinic multinational study published for Restorative Reproductive Medicine, and specifically for NaProTechnology.
The International Natural Procreative Technology Evaluation and Surveillance of Treatment for Sub-fertility (iNEST) worked to establish and build more robust outcomes research for Restorative Reproductive Medicine. Dr. Joseph Stanford, joined by some of the co-authors on the paper and involved in the study will present. Please download the article ahead of the webinar here.
Approved for 1.0 Online Only, Live AAFP Prescribed Credit*
Dr. Stanford is the Director of the Office of Cooperative Reproductive Health and Professor in the Department of Family Preventive Medicine, at the University of Utah in Salt Lake City. He has authored or coauthored numerous articles concerning pregnancy, prenatal care, natural family planning, fertility, and related topics. His research has been funded by the NICHD, the CDC, and several private foundations.
Dr. Stanford is actively involved in many professional associations, including the Society for Pediatric and Perinatal Epidemiologic Research, the AAFCP, and the IIRRM. He has served on national scientific advisory committees for the NICHD and the FDA in the USA.